Form 4: Fulgent Genetics' Chief Scientific Officer Sells Shares to Cover Tax Obligations

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,503 shares of common stock on September 3, 2024, to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Hanlin Gao, the Chief Scientific Officer of Fulgent Genetics, sold 1,503 shares of the company's common stock on September 3, 2024.
• The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 28, 2022.
• The shares were sold at a weighted-average price of $21.961, with individual transactions ranging from $21.815 to $22.10.
• Following the transaction, Gao directly owns 923,057 shares of Fulgent Genetics.
• The sale was reported on a Form 4 filing with the Securities and Exchange Commission on September 5, 2024.

Sentiment

Score: 5

Explanation: The document reports a routine transaction (sale of shares to cover taxes) by an executive, which is neither particularly positive nor negative.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and officers.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial performance.

Key Dates